Great post. I'm very excited for 2021. Looks like it could be a good year for CYP with them moving forward with some big investors backing them. Time for Cynata to be recognised as a new leader in cellular medicine.
The science is continually evolving and Cynata is in prime position to learn from it's bigger brother and take the lead.
These shares under 70 cents the last few days were an earlier Christmas present
Merry Christmas fellow cynatas
CYNATA - 2021 The Year of Multiple Trials, page-3
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9966 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 5795 | 1 |
View Market Depth
| Last trade - 10.02am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
31.0¢ |
Change
0.000 ( 3.13 %) |
||||
| Open | High | Low | Volume | ||
| 34.0¢ | 34.0¢ | 31.0¢ | 33184 | ||
| Last updated 10.17am 30/05/2024 ? | |||||
| CYP (ASX) Chart |
Day chart unavailable